A service break in our online ordering portal Nucleus is scheduled to start on August 21 at 9pm (EEST)/ August 21 at 2pm (EST)/ August 22 at 4am (AEST) and it is estimated to end on August 23 at 9pm (EEST)/ August 23 at 2pm (EST)/ August 24 at 4am (AEST). Nucleus will not be accessible during this time. We apologize for the inconvenience.
This article from the American Academy of Ophthalmology explores the different genetic testing platforms and evaluates the technologies available to aid in the diagnosis of inherited retinal degenerations (IRDs). This analysis aims to address the complexities ophthalmologists face when looking to order genetic testing for their IRD patients. Blueprint Genetics’ Inherited Retinal Disorders panel is one of the three IRD panel tests investigated. This review highlights the importance of choosing a panel validated to sequence difficult-to-sequence genes such as RPGR in addition to being able to capture non-coding variants in IRD genes to increase the chances of obtaining a diagnosis in affected individuals.
Please be advised that a specimen collection kit must be requested by a medical professional.
If you are a patient or family member of a patient, please contact your provider to place a kit order on your behalf.